Pancreatic Cancer Research

ResearcherUniversity of MiamiActive in the last 2 years

Oliver Gene McDonald

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6602-7535; OpenAlex author ID A5043640546, A5135201577; NIH RePORTER profile ID 10983937. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 3)
Trials
0
Grants
1
Labs led
2
Collaborators
31
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper, 1 grant

Papers 7

  1. Comparative Analysis of Primary and Liver Fibroblasts Reveals MET as a Potent Target in Pancreatic Cancer Metastasis. Co-author DOI 10.1016/j.jcmgh.2026.101872↗
  2. Targeting CREB remodels the immune microenvironment to enhance immunotherapy responses in pancreatic cancer Co-author DOI 10.64898/2025.12.04.691935↗
  3. Pancreatic cancer epigenetics: adaptive metabolism reprograms starving primary tumors for widespread metastatic outgrowth. Last author DOI 10.1007/s10555-023-10116-z↗
  4. The biology of pancreatic cancer morphology. Co-author DOI 10.1016/j.pathol.2021.09.012↗
  5. Aminopyridine analogs selectively target metastatic pancreatic cancer. Last author DOI 10.1038/s41388-022-02183-3↗
  6. Pentose conversions support the tumorigenesis of pancreatic cancer distant metastases. Last author DOI 10.1038/s41388-018-0346-5↗
  7. Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis. Co-author DOI 10.1038/ng.3753↗

Grants 1

  1. The Evolution of PGD Addiction in Human Pancreatic Cancer R01CA222594↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Arnaldo Franco · 1 shared paper, 2023 · strength 0.31
  2. Matthew E. Bechard · 2 shared papers, 2018–2022 · strength 0.25
  3. Nikki K. Lytle · 1 shared paper, 2026 · strength 0.23
  4. Christopher J. Halbrook · 1 shared paper, 2026 · strength 0.23
  5. Nina G. Steele · 1 shared paper, 2026 · strength 0.23
  6. Austin D. Silva · 1 shared paper, 2026 · strength 0.23
  7. David K. Imagawa · 1 shared paper, 2026 · strength 0.23
  8. Rima Singh · 1 shared paper, 2026 · strength 0.23
  9. Ian M. Loveless · 1 shared paper, 2026 · strength 0.23
  10. Zeljka Jutric · 1 shared paper, 2026 · strength 0.23
  11. Mohammed Aldakkak · 1 shared paper, 2026 · strength 0.23
  12. Alica K. Michels · 1 shared paper, 2026 · strength 0.23
  13. Jennifer P. Morton · 1 shared paper, 2026 · strength 0.23
  14. Kathleen E. DelGiorno · 1 shared paper, 2025 · strength 0.19
  15. Austin R. Dosch · 1 shared paper, 2025 · strength 0.19
  16. Vineet Kumar Gupta · 1 shared paper, 2025 · strength 0.19
  17. Jashodeep Datta · 1 shared paper, 2025 · strength 0.19
  18. Haleh Amirian · 1 shared paper, 2025 · strength 0.19
  19. Siddharth Mehra · 1 shared paper, 2025 · strength 0.19
  20. Supriya Srinivasan · 1 shared paper, 2025 · strength 0.19
  21. Nipun B. Merchant · 1 shared paper, 2025 · strength 0.19
  22. Nagaraj S. Nagathihalli · 1 shared paper, 2025 · strength 0.19
  23. Rana V. Smalling · 1 shared paper, 2022 · strength 0.16
  24. Alvin P. Makohon-Moore · 1 shared paper, 2017 · strength 0.05
  25. Andrew P. Feinberg · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.